stockrow
Saturday 7 November 2026
Export NVNO’s income statement to Excel — free account
enVVeno Medical Corporation
NVNO Healthcare Medical Devices
- EPS
- +22.0%
- Free cash flow
- +27.6%
Quarter to September 2026, against a year earlier
6.39
0.58
−8.32%
Follow NVNO
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (67.11%) | (58.53%) | (60.65%) | (56.21%) |
+8 more TTM periods Free account |
|
| (60.00%) | (53.09%) | (56.45%) | (52.26%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(94.29%) | (77.56%) | (80.55%) | (72.78%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(19.32) | (21.79) | (22.61) | (26.45) | |
Free Cash Flow |
(13.41) | (14.62) | (14.79) | (15.58) | |
Capital Expenditures |
— | — | — | (0.01) | |
| Other line items | |||||
Cash ROIC |
(37.91%) | (34.69%) | (30.38%) | (28.15%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.86 | 0.93 | 0.79 | 0.80 | |
Depreciation/Fixed assets |
6.13 | 5.00 | 30.69 | 9.59 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.02) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(19.32) | (21.79) | (22.61) | (26.43) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.02) | |
Capex to Sales |
— | — | — | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026